ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 270 filers reported holding ALKERMES PLC in Q2 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $225,000 | -79.9% | 6,582 | -53.3% | 0.02% | -79.5% |
| Q4 2015 | $1,119,000 | +35.3% | 14,091 | 0.0% | 0.08% | +27.7% |
| Q3 2015 | $827,000 | -8.6% | 14,091 | +0.1% | 0.06% | +30.0% |
| Q2 2015 | $905,000 | +5.5% | 14,073 | 0.0% | 0.05% | +31.6% |
| Q1 2015 | $858,000 | +4.1% | 14,073 | 0.0% | 0.04% | +2.7% |
| Q4 2014 | $824,000 | +36.7% | 14,073 | 0.0% | 0.04% | +37.0% |
| Q3 2014 | $603,000 | -7.9% | 14,073 | +8.1% | 0.03% | -3.6% |
| Q2 2014 | $655,000 | +14.1% | 13,013 | 0.0% | 0.03% | +7.7% |
| Q1 2014 | $574,000 | +8.5% | 13,013 | 0.0% | 0.03% | +13.0% |
| Q4 2013 | $529,000 | +134.1% | 13,013 | +94.0% | 0.02% | +109.1% |
| Q3 2013 | $226,000 | – | 6,709 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |